Black checkmark with a sparkle and a curved line underneath on a white background.
Company

Teladoc Health, Inc.

Ticker
TDOC
Sector
Industry
Report date
October 29, 2026
Valye AI Score

99

Very high visibility
Recent developments
Recent developments summary

Recent developments highlight Teladoc Health's Q3 2026 financial results, technology enhancements, and operational challenges in the BetterHelp segment.

Recent developments:
  • Teladoc Health reported Q3 2026 revenue of $605.1 million and a net loss of $26.9 million, with EPS of -$0.15 [N2][N4][S2].
  • The company continues to strengthen its Solo platform with new AI-powered care tools aimed at hospital and health system markets [N6].
  • BetterHelp segment faces revenue pressure due to declines in cash-paying users and challenges in expanding insurance-covered services, leading to reduced marketing spend to align demand with provider capacity [S2].
  • Q2 2026 earnings highlighted strength in integrated care offerings and ongoing efforts to improve clinical and operational performance [N7][N8].
  • Teladoc's Q3 2026 earnings call provided insights into key metrics and operational priorities [N1][N3].
Overview

Teladoc Health, Inc. is a virtual healthcare company with over 20 years of experience, offering integrated virtual care services globally. It operates two reportable segments: Integrated Care, which provides a broad range of virtual clinical services to over 100 million members primarily through employers and insurers, and BetterHelp, a leading virtual mental health platform. The company generates most of its revenue from recurring access fees and visit fees, supplemented by hardware and software sales to healthcare providers. Teladoc leverages proprietary technology platforms, including the Teladoc Health Prism and Solo platforms, and advanced AI and data analytics to deliver personalized, scalable care. It emphasizes clinical quality and safety, supported by a dedicated Patient Safety Organization. As of Q3 2026, Teladoc reported $605.1 million in revenue and a net loss of $26.9 million, with liquidity ratios indicating moderate short-term financial flexibility. The BetterHelp segment is undergoing a transition with increased insurance coverage utilization impacting revenue dynamics and marketing strategies.

Executive summary

Teladoc Health, Inc. is a global leader in virtual care, operating two main segments: Integrated Care and BetterHelp. The company provides a comprehensive suite of virtual healthcare services leveraging proprietary technology platforms and advanced AI-driven analytics. As of September 30, 2026, Teladoc reported $605.1 million in Q3 revenue with a net loss of $26.9 million and maintains significant liquidity with $849.9 million in cash and equivalents. The BetterHelp segment faces challenges related to shifting revenue mix from cash-paying to insurance-covered users and capacity constraints in provider network expansion. Teladoc continues to invest in technology enhancements, including AI-powered tools for its Solo platform serving hospitals and health systems. Financial figures (if any) are summarized from the latest available SEC filings and are provided for informational purposes only — not financial advice.

Scenarios for TDOC

Bull case model:

Teladoc Health's extensive virtual care platform and global reach position it to address a wide spectrum of healthcare needs, from preventive to complex care. Its integration of AI and machine learning enhances personalized care delivery and operational efficiency. The company's ongoing technology enhancements, such as AI-powered tools for hospital telehealth solutions, support expansion into hybrid care models. Continued growth in insurance coverage for mental health services via BetterHelp could diversify revenue streams. Teladoc's strong clinical quality focus and data-driven engagement model may drive higher utilization and improved health outcomes, potentially increasing client value and retention.

Bear case model:

Challenges in the BetterHelp segment include declining revenue from cash-paying users as insurance coverage expands, coupled with capacity constraints in recruiting and retaining credentialed providers to meet insurance demand. Reduced marketing spend to align demand with capacity may limit user acquisition and near-term revenue growth. The company's current liquidity ratios below 1.0 indicate potential short-term financial constraints. Competitive pressures in virtual care and regulatory changes could impact business operations. Execution risks exist in scaling integrated care offerings and technology platforms while maintaining clinical quality and cost efficiency.

Moat:

Teladoc Health's competitive advantages stem from its comprehensive and integrated virtual care offerings, extensive global footprint, and proprietary technology platforms developed over two decades. Its scale and first-mover status provide significant barriers to entry, enabling broad client reach across employers, insurers, hospitals, and individuals. The company's advanced AI-driven analytics and engagement science enhance member utilization and clinical outcomes, differentiating its services. Additionally, Teladoc's commitment to clinical quality, safety, and regulatory compliance, including its certified Patient Safety Organization, reinforces trust and reliability. Its ability to integrate with diverse healthcare systems and payors through APIs further strengthens its position as a long-term partner in virtual care delivery.

Risks overview
Risks summary
The most significant risk is the BetterHelp segment's revenue challenges due to shifts from cash-paying to insurance-covered users combined with provider capacity constraints, which may impact overall financial performance.
Risks details:

• BetterHelp Revenue Mix Shift: Declines in cash-paying users and challenges in expanding insurance-covered services may adversely affect revenue and overall segment performance.
• Provider Network Capacity: Inability to recruit and retain sufficient credentialed providers to meet insurance demand could limit revenue growth and service availability.
• Marketing Spend Reduction: Reduced advertising and marketing to align demand with capacity may result in fewer paying users and lower revenue.
• Liquidity Constraints: Current ratio below 1.0 as of September 30, 2026, indicates potential short-term liquidity pressures.
• Competitive and Regulatory Risks: Intense competition in virtual care and evolving healthcare regulations may impact business operations and growth.

FINAL FORECAST FOR TDOC

Final take one line
Teladoc Health exhibits very high visibility with a comprehensive virtual care platform, detailed financial disclosures, and clear strategic focus amid evolving revenue dynamics in its mental health segment.
Final take 12 to 24 month view

Business trends: Expansion of integrated virtual care services with increasing AI and data analytics integration; shifting revenue mix in mental health segment from cash-pay to insurance coverage.
Execution milestones: Enhancements to Solo platform with AI-powered tools; scaling provider network capacity for BetterHelp; managing marketing spend to align with capacity.
Key risks: Revenue pressure from BetterHelp's changing user payment mix and provider capacity constraints; liquidity challenges; competitive and regulatory environment.

Valye AI Visibility Research Score

Very high visibility

Visibility score reflects the breadth and consistency of available disclosure across SEC filings, recent public reporting, and baseline business context (research-only; not investment advice).

99
LLM visibility overview
LLM Visibility known facts
  • Teladoc Health is a global leader in virtual care with over 20 years of history, aiming to provide access to high-quality healthcare anywhere on patients' terms [S1].
  • The company operates two main segments: Integrated Care and BetterHelp, serving over 100 million members primarily in the U.S. as of December 31, 2025 [S1].
  • Integrated Care delivers virtual care services including preventive, primary, urgent, mental health, chronic care, and expert second opinions, primarily through B2B contracts with employers, health plans, hospitals, and insurers [S1].
  • BetterHelp is a leading virtual mental health platform with nearly 35,000 licensed clinicians providing counseling via web, mobile app, phone, and text [S1].
  • Revenue is primarily generated from access fees (83% of consolidated revenue in 2025), mostly on a recurring per-member-per-month or similar basis, with additional revenue from visit fees and sales of hardware and services to hospitals and health systems [S1].
  • Teladoc Health offers a comprehensive suite of virtual care clinical services and proprietary technology platforms including the Teladoc Health Prism care delivery platform and Solo platform for hospitals and health systems [S1].
  • The company leverages AI, machine learning, and advanced data analytics through its Teladoc Health Pulse intelligence engine to personalize care, optimize experiences, and improve clinical outcomes [S1].
  • Teladoc Health has a global footprint with a diverse client base and a broad distribution network reaching individuals and organizations worldwide [S1].
  • The company emphasizes clinical quality and safety, operating a dedicated Patient Safety Organization certified by the Agency for Healthcare Research and Quality [S1].
  • Financial snapshot as of September 30, 2026: cash and equivalents of $849.9 million, current assets of $1.23 billion, current liabilities of $1.42 billion, resulting in a current ratio of 0.87 and cash ratio of 0.63 [S2].
  • For Q3 2026, Teladoc Health reported revenue of $605.1 million and a net loss of $26.9 million, with basic and diluted EPS of -$0.15 [S2][N2][N4].
  • The BetterHelp segment is experiencing shifts from cash-paying users to insurance-covered users, which has led to revenue challenges and capacity constraints in provider network expansion [S2].
  • Marketing spend for BetterHelp has been reduced to align demand with provider capacity, impacting user acquisition and near-term revenue [S2].
  • Teladoc Health continues to enhance its Solo platform with new AI-powered care tools to strengthen hospital and health system offerings [N6].
  • The company reported Q2 2026 earnings with strength in integrated care and highlighted ongoing efforts to improve clinical and operational performance [N7][N8].
Sources
Sources - Context summary

Generated 2026-10-29

Sources - Earning calls
  • N1
  • N7
  • N8
Sources - Other context
Sources - SEC Filings
  • S1 | 2026-02-26 | 10-K
  • S2 | 2026-10-29 | 10-Q
Sources - News headlines
  • N1 | 2026-10-29 | www.nasdaq.com | Teladoc (TDOC) Q3 2026 Earnings Call Transcript | https://www.nasdaq.com/articles/teladoc-tdoc-q3-2026-earnings-call-transcript
  • N2 | 2026-10-28 | www.nasdaq.com | Teladoc Health, Inc. Reports Third Quarter 2026 Revenue of $605.1 million | https://www.nasdaq.com/articles/teladoc-health-inc-reports-third-quarter-2026-revenue-6051-million
  • N3 | 2026-10-28 | www.nasdaq.com | Teladoc (TDOC) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates | https://www.nasdaq.com/articles/teladoc-tdoc-q3-earnings-taking-look-key-metrics-versus-estimates
  • N4 | 2026-10-28 | www.nasdaq.com | Teladoc (TDOC) Reports Q3 Loss, Beats Revenue Estimates | https://www.nasdaq.com/articles/teladoc-tdoc-reports-q3-loss-beats-revenue-estimates
  • N5 | 2026-10-27 | www.nasdaq.com | Unveiling Teladoc (TDOC) Q3 Outlook: Wall Street Estimates for Key Metrics | https://www.nasdaq.com/articles/unveiling-teladoc-tdoc-q3-outlook-wall-street-estimates-key-metrics
  • N6 | 2026-10-08 | www.nasdaq.com | Teladoc Strengthens Solo Platform With New AI-Powered Care Tools | https://www.nasdaq.com/articles/teladoc-strengthens-solo-platform-new-ai-powered-care-tools
  • N7 | 2026-07-30 | www.nasdaq.com | Teladoc Health Q2 Earnings Beat Estimates on Integrated Care Strength | https://www.nasdaq.com/articles/teladoc-health-q2-earnings-beat-estimates-integrated-care-strength
  • N8 | 2026-07-30 | www.nasdaq.com | Teladoc Health Q2 Earnings Call Highlights | https://www.nasdaq.com/articles/teladoc-health-q2-earnings-call-highlights
Important legal disclaimer

This material is for informational purposes only and does not constitute investment, financial, legal or tax advice, or an offer or solicitation to buy or sell any security. The Valye AI Score is a model-based estimate derived from public information and is subject to change without notice. No representation or warranty, express or implied, is made as to the accuracy, completeness or fairness of the information herein. Past performance is not indicative of future results. Investors should conduct their own research and consult a qualified financial adviser before making any investment decisions.

Blue logo with a stylized checkmark and star above the blue text 'VALYE' on a black background.

Generated by Valye SEC Pipeline Engine